Core Scientific (CORZ) Liabilities and Shareholders Equity (2020 - 2026)

Core Scientific (CORZ) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $3.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 104.9% year-over-year to $3.1 billion; the trailing twelve-month figure through Mar 2026 stood at $9.4 billion (up 111.51% YoY), and the FY2025 full-year result was $2.3 billion, up 59.06% from the prior year.
• Liabilities and Shareholders Equity rose to $3.1 billion in Q1 2026, from $2.3 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.1 billion in Q1 2026 to a low of $664.2 million in Q2 2024.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity jumped 677.6% in 2022 and sank 71.89% in 2023, its largest moves.
• Tracing CORZ's Liabilities and Shareholders Equity over 5 years: stood at $807.7 million in 2022, then decreased by 11.83% to $712.2 million in 2023, then jumped by 107.25% to $1.5 billion in 2024, then soared by 59.06% to $2.3 billion in 2025, then jumped by 30.75% to $3.1 billion in 2026.
• Business Quant data shows CORZ's Liabilities and Shareholders Equity at $3.1 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.2 billion in Q3 2025.